PortfoliosLab logoPortfoliosLab logo
BCAB vs. OLPX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BCAB vs. OLPX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioAtla, Inc. (BCAB) and Olaplex Holdings, Inc. (OLPX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BCAB achieves a -87.25% return, which is significantly lower than OLPX's 53.73% return.


BCAB

1D
-0.96%
1M
-1.90%
YTD
-87.25%
6M
-90.93%
1Y
-81.96%
3Y*
-72.55%
5Y*
-71.61%
10Y*

OLPX

1D
0.49%
1M
0.49%
YTD
53.73%
6M
59.69%
1Y
42.07%
3Y*
-15.87%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BCAB vs. OLPX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
BCAB
BioAtla, Inc.
-87.25%-3.97%-75.97%-70.18%-57.97%-36.66%
OLPX
Olaplex Holdings, Inc.
53.73%-22.54%-31.89%-51.25%-82.11%16.52%

Correlation

The correlation between BCAB and OLPX is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Sep 30, 2021

0.22

The correlation between BCAB and OLPX shifts across timeframes, from 0.05 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS

BCAB:

-$1.10

OLPX:

-$0.02

Total Revenue (TTM)

BCAB:

$0.00

OLPX:

$425.35M

Gross Profit (TTM)

BCAB:

-$12.46M

OLPX:

$276.19M

EBITDA (TTM)

BCAB:

-$67.70M

OLPX:

$50.63M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BCAB vs. OLPX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BCAB
BCAB Risk / Return Rank: 1313
Overall Rank
BCAB Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
BCAB Sortino Ratio Rank: 1414
Sortino Ratio Rank
BCAB Omega Ratio Rank: 1515
Omega Ratio Rank
BCAB Calmar Ratio Rank: 88
Calmar Ratio Rank
BCAB Martin Ratio Rank: 1010
Martin Ratio Rank

OLPX
OLPX Risk / Return Rank: 6565
Overall Rank
OLPX Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
OLPX Sortino Ratio Rank: 6969
Sortino Ratio Rank
OLPX Omega Ratio Rank: 6969
Omega Ratio Rank
OLPX Calmar Ratio Rank: 6464
Calmar Ratio Rank
OLPX Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BCAB vs. OLPX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BioAtla, Inc. (BCAB) and Olaplex Holdings, Inc. (OLPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BCABOLPXDifference
Sharpe ratioReturn per unit of total volatility

-1.14

Sortino ratioReturn per unit of downside risk

-2.43

Omega ratioGain probability vs. loss probability

0.90

1.21

-0.31

Calmar ratioReturn relative to maximum drawdown

-0.87

1.06

-1.93

Martin ratioReturn relative to average drawdown

-1.33

2.29

-3.62

BCAB vs. OLPX - Sharpe Ratio Comparison

The current BCAB Sharpe Ratio is -0.62, which is lower than the OLPX Sharpe Ratio of 0.53. The chart below compares the historical Sharpe Ratios of BCAB and OLPX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BCAB vs. OLPX - Drawdown Comparison

The maximum BCAB drawdown since its inception was -99.91%, roughly equal to the maximum OLPX drawdown of -96.57%. Use the drawdown chart below to compare losses from any high point for BCAB and OLPX.


Loading charts...

Drawdown Indicators


BCABOLPXDifference

Max Drawdown

Largest peak-to-trough decline

-99.91%

-96.57%

-3.34%

Max Drawdown (1Y)

Largest decline over 1 year

-94.57%

-39.88%

-54.69%

Max Drawdown (3Y)

Largest decline over 3 years

-98.31%

-76.12%

-22.19%

Max Drawdown (5Y)

Largest decline over 5 years

-99.85%

Current Drawdown

Current decline from peak

-99.90%

-93.00%

-6.90%

Average Drawdown

Average peak-to-trough decline

-84.84%

-79.67%

-5.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

61.49%

18.45%

+43.04%

Volatility

BCAB vs. OLPX - Volatility Comparison

BioAtla, Inc. (BCAB) has a higher volatility of 22.89% compared to Olaplex Holdings, Inc. (OLPX) at 2.16%. This indicates that BCAB's price experiences larger fluctuations and is considered to be riskier than OLPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BCABOLPXDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.89%

2.16%

+20.73%

Volatility (6M)

Calculated over the trailing 6-month period

101.19%

59.60%

+41.59%

Volatility (1Y)

Calculated over the trailing 1-year period

133.67%

80.14%

+53.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

118.50%

76.97%

+41.53%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

115.06%

76.97%

+38.09%

Dividends

BCAB vs. OLPX - Dividend Comparison

Neither BCAB nor OLPX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

BCAB vs. OLPX - Financials Comparison

This section allows you to compare key financial metrics between BioAtla, Inc. and Olaplex Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M202220232024202520260
99.37M
(BCAB) Total Revenue
(OLPX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


BCAB and OLPX have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BCAB has higher volatility (22.89%) compared to OLPX (2.16%). In terms of maximum drawdown, BCAB dropped -99.91% vs OLPX's -96.57%.

OLPX currently has the higher Sharpe Ratio (0.53 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BCAB and OLPX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer